The JAK2 V617F mutation in lung cancer: caveat emptor
As acquisition of the JAK2 V617F is considered to be restricted to myeloid malignancies, the recurrent identification of this mutation in non-small cell lung cancer (NSCLC) merits discussion, particularly in the light of accumulating evidence which suggests that the JAK2 V617F may...
Saved in:
| Date: | 2018 |
|---|---|
| Main Author: | Langabeer, S.E. |
| Format: | Article |
| Language: | English |
| Published: |
PH Akademperiodyka
2018
|
| Subjects: | |
| Online Access: | https://exp-oncology.com.ua/index.php/Exp/article/view/2018-4-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Experimental Oncology |
Institution
Experimental OncologySimilar Items
Detection of V617F mutation of gene jak2 at patients with chronic myeloproliferative neoplasms
by: Dybkov, M.V., et al.
Published: (2010)
by: Dybkov, M.V., et al.
Published: (2010)
Application of the Concept of ‘Caveat Emptor’ in The Context of Consumer Obligations
by: R. V. Pozhodzhuk
Published: (2024)
by: R. V. Pozhodzhuk
Published: (2024)
Мутація V617F гена jak2 як молекулярно-генетичний маркер у хворих на хронічні мієлопроліферативні захворювання
by: Дибков, М.В., et al.
Published: (2009)
by: Дибков, М.В., et al.
Published: (2009)
Розробка тест-системи для виявлення мутації V617F гена jak2 у хворих на хронічні мієлопроліферативні захворювання
by: Дибков, М.В., et al.
Published: (2009)
by: Дибков, М.В., et al.
Published: (2009)
Виявлення мутації V617F в гені jak2 хворих на хронічні мієлопроліферативні неоплазми за допомогою T-ARMS ПЛР
by: Дибков, М.В., et al.
Published: (2010)
by: Дибков, М.В., et al.
Published: (2010)
Гістологічні критерії диференційної діагностики справжньої поліцитемії і вторинних еритроцитозів та їх зв’язок із наявністю мутації JAK2 V617F
by: Коваль, А.І., et al.
Published: (2014)
by: Коваль, А.І., et al.
Published: (2014)
\(F\)-supplemented modules
by: Özdemir, S.
Published: (2020)
by: Özdemir, S.
Published: (2020)
Anagrelide and the CALR mutation allele burden in essential thrombocythemia
by: Atkinson, E., et al.
Published: (2018)
by: Atkinson, E., et al.
Published: (2018)
ATYPICAL BRAF MUTATIONS IN HAIRY CELL LEUKEMIA: DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONS
by: LANGABEER, S.E., et al.
Published: (2025)
by: LANGABEER, S.E., et al.
Published: (2025)
On the mutation loops of valued quivers
by: Saleh, I.
Published: (2023)
by: Saleh, I.
Published: (2023)
Paraneoplastic syndrome in lung cancer
by: Dumansky, Yu.V., et al.
Published: (2018)
by: Dumansky, Yu.V., et al.
Published: (2018)
Paraneoplastic syndrome in lung cancer
by: Dumansky, Yu.V., et al.
Published: (2018)
by: Dumansky, Yu.V., et al.
Published: (2018)
Word length in symmetrized presentations of Thompson's group \(F\)
by: Horak, Matthew, et al.
Published: (2018)
by: Horak, Matthew, et al.
Published: (2018)
Endothelial dysfunction of vessels at lung cancer
by: Yu. V. Dumanskiy, et al.
Published: (2015)
by: Yu. V. Dumanskiy, et al.
Published: (2015)
Endothelial dysfunction of vessels at lung cancer
by: Dumanskiy, Yu.V., et al.
Published: (2015)
by: Dumanskiy, Yu.V., et al.
Published: (2015)
Histogenesis of central lung cancer: cytological investigation
by: Bolgova, L.S., et al.
Published: (2023)
by: Bolgova, L.S., et al.
Published: (2023)
Treatment of patients with kidney cancer metastases to the lungs
by: A. G. Kudrjashov, et al.
Published: (2012)
by: A. G. Kudrjashov, et al.
Published: (2012)
The state of bone metabolism in lung cancer patients
by: Dumansky, Y.V., et al.
Published: (2018)
by: Dumansky, Y.V., et al.
Published: (2018)
Evolutionary karyotypic theory of cancer versus conventional cancer gene mutation theory
by: A. A. Stepanenko, et al.
Published: (2012)
by: A. A. Stepanenko, et al.
Published: (2012)
Evolutionary karyotypic theory of cancer versus conventional cancer gene mutation theory
by: Stepanenko, A.A., et al.
Published: (2012)
by: Stepanenko, A.A., et al.
Published: (2012)
Anti-tori in quaternionic lattices over \(\mathbb{F}_q(t)\)
by: Bondarenko, Ievgen, et al.
Published: (2024)
by: Bondarenko, Ievgen, et al.
Published: (2024)
Mobile genetic elements and cancer. From mutations to gene therapy
by: Kozeretska, I.A., et al.
Published: (2011)
by: Kozeretska, I.A., et al.
Published: (2011)
Список работ В.В. Крапивиной
Published: (2015)
Published: (2015)
Ольвия и сарматы
by: Крапивина, В.В.
Published: (2015)
by: Крапивина, В.В.
Published: (2015)
Фототека. Валентина Крапивина и мы
Published: (2015)
Published: (2015)
Памяти В.В. Крапивиной
Published: (2015)
Published: (2015)
Unusual metastases of lung cancer: bulbus oculi and maxillary sinus
by: I. Ates, et al.
Published: (2015)
by: I. Ates, et al.
Published: (2015)
Computational analysis of microarray gene expression profiles of lung cancer
by: S. A. Babichev, et al.
Published: (2016)
by: S. A. Babichev, et al.
Published: (2016)
The dynamics of element content in patients with lung cancer during radiotherapy
by: Dikiy, N.P., et al.
Published: (2009)
by: Dikiy, N.P., et al.
Published: (2009)
Adsorption-rheological properties of blood serum in lung cancer patients
by: Dumanskiy, Y.V., et al.
Published: (2017)
by: Dumanskiy, Y.V., et al.
Published: (2017)
Computational analysis of microarray gene expression profiles of lung cancer
by: Babichev, S.A., et al.
Published: (2016)
by: Babichev, S.A., et al.
Published: (2016)
Unusual metastases of lung cancer: bulbus oculi and maxillary sinus
by: Ates, I., et al.
Published: (2015)
by: Ates, I., et al.
Published: (2015)
Mutations in MEFV cause alterations in neutrophil F-actin and phagocytosis dynamics
by: Davtyan, T.K., et al.
Published: (2011)
by: Davtyan, T.K., et al.
Published: (2011)
On the \(\cal F\) -hypercentre of a finite group
by: Skiba, Alexander N.
Published: (2018)
by: Skiba, Alexander N.
Published: (2018)
Adenocarcinoma of the lung with rare insertion mutation in egfr exon 19 that had partial response to gefitinib: a case report
by: Kozlov, V., et al.
Published: (2017)
by: Kozlov, V., et al.
Published: (2017)
Synergistic effects of taurine and cisplatin on lung cancer cells (A549)
by: F. J. Jouni, et al.
Published: (2023)
by: F. J. Jouni, et al.
Published: (2023)
The effectiveness of adjuvant chemoradiotherapy in patients with non-small-cell lung cancer
by: Ju. Basilajshvili
Published: (2015)
by: Ju. Basilajshvili
Published: (2015)
The clinical significance of soluble E-cadherin in nonsmall cell lung cancer
by: Charalabopoulos, K., et al.
Published: (2006)
by: Charalabopoulos, K., et al.
Published: (2006)
Ovarian cancer: family cancer syndrome and clinical significance of testing of the mutations in BRCA1 and BRCA2?genes
by: O. V. Paliichuk, et al.
Published: (2016)
by: O. V. Paliichuk, et al.
Published: (2016)
Mutation 6174delT in the BRCA2 gene in men with prostate cancer in Ukraine
by: Ye. V. Horodetska, et al.
Published: (2018)
by: Ye. V. Horodetska, et al.
Published: (2018)
Similar Items
-
Detection of V617F mutation of gene jak2 at patients with chronic myeloproliferative neoplasms
by: Dybkov, M.V., et al.
Published: (2010) -
Application of the Concept of ‘Caveat Emptor’ in The Context of Consumer Obligations
by: R. V. Pozhodzhuk
Published: (2024) -
Мутація V617F гена jak2 як молекулярно-генетичний маркер у хворих на хронічні мієлопроліферативні захворювання
by: Дибков, М.В., et al.
Published: (2009) -
Розробка тест-системи для виявлення мутації V617F гена jak2 у хворих на хронічні мієлопроліферативні захворювання
by: Дибков, М.В., et al.
Published: (2009) -
Виявлення мутації V617F в гені jak2 хворих на хронічні мієлопроліферативні неоплазми за допомогою T-ARMS ПЛР
by: Дибков, М.В., et al.
Published: (2010)